Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 180
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Title
Phase
Protocol IDs
Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis
Phase IV
CZOL446EDE15
NCT00172003
Sorafenib Hypophosphatemia Study
Phase IV
12345
N.A., NCT00622479
Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®
Phase IV
A6181171
NCT00684645
Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma
Phase IV
A6181132
NCT00706706
Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors
Phase IV
UMCNONCO200801
NCT00777504
Comparison Between Surgery and Radiofrequency for Treatment of Renal Tumors
Phase III, Phase II
9359-03
2003-006, NCT00221728
ABR-217620 With Interferon-Alpha (IFN-Alpha) Compared to IFN-Alpha Alone in Patients With Advanced Renal Cell Carcinoma
Phase III, Phase II
06762004
NCT00420888
SU011248 versus Interferon-alfa as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma
Phase III
A6181034
NCT00083889
Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
Phase III
A6181037
NCT00130897
Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery
Phase III
ECOG-E2805
E2805, CALGB-E2805, SWOG-E2805, CAN-NCIC-E2805, NCT00326898
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute